Medline Inc.
MDLN
$41.46
$0.390.95%
NASDAQ
| 12/31/2025 | 09/27/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 9.44% | 3.33% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.44% | 3.33% | |||
| Cost of Revenue | 12.08% | 5.20% | |||
| Gross Profit | 2.08% | -1.57% | |||
| SG&A Expenses | 13.35% | 2.76% | |||
| Depreciation & Amortization | -0.56% | 0.57% | |||
| Other Operating Expenses | 275.00% | -42.86% | |||
| Total Operating Expenses | 12.28% | 4.54% | |||
| Operating Income | -22.82% | -8.74% | |||
| Income Before Tax | -40.29% | -3.90% | |||
| Income Tax Expenses | 13.04% | -11.54% | |||
| Earnings from Continuing Operations | -44.10% | -3.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -43.48% | -3.30% | |||
| EBIT | -22.82% | -8.74% | |||
| EBITDA | -14.87% | -5.75% | |||
| EPS Basic | 1,117.93% | -3.16% | |||
| Normalized Basic EPS | 1,605.56% | 1.61% | |||
| EPS Diluted | 1,117.93% | -3.16% | |||
| Normalized Diluted EPS | 1,605.56% | 1.61% | |||
| Average Basic Shares Outstanding | -95.35% | -0.13% | |||
| Average Diluted Shares Outstanding | -95.35% | -0.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 0.43% | -0.19% | |||